Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jeannette M, Dowell"'
Autor:
James E. Herndon, Sith Sathornsumetee, James J. Vredenburgh, Jennifer A. Quinn, Annick Desjardins, David A. Reardon, Darell D. Bigner, Sridharan Gururangan, Jeannette M. Dowell, Henry S. Friedman, Melissa Wagner, Allan H. Friedman, Jeremy N. Rich
Publikováno v:
Clinical Cancer Research. 13:1253-1259
Purpose: Recurrent grade III-IV gliomas have a dismal prognosis with minimal improvements in survival seen following currently available salvage therapy. This study was conducted to determine if the combination of a novel antiangiogenic therapy, beva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae531b9a215eec5f03cdbdcbc850cc0
https://doi.org/10.1158/1078-0432.ccr-06-2309
https://doi.org/10.1158/1078-0432.ccr-06-2309
Autor:
James E. Herndon, David A. Reardon, Darell D. Bigner, Gregory J. Riggins, Chien-Tsun Kuan, Michael W. Graner, Jeannette M. Dowell, Carol J. Wikstrand, Kenji Wakiya
Publikováno v:
Clinical Cancer Research. 12:1970-1982
Purpose: More brain tumor markers are required for prognosis and targeted therapy. We have identified and validated promising molecular therapeutic glioblastoma multiforme (GBM) targets: human transmembrane glycoprotein nonmetastatic melanoma protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13632f33f8fbcb48894a1647e284231
https://doi.org/10.1158/1078-0432.ccr-05-2797
https://doi.org/10.1158/1078-0432.ccr-05-2797
Autor:
Mark Redston, Jeannette M. Dowell, Robert J. Mayer, James M. Fleshman, Carolyn C. Compton, Monica M. Bertagnolli, Scott D. Jewell, Brent W. Miedema, Jiri Bem, Donna Niedzwiecki
Publikováno v:
Journal of Clinical Oncology. 24:878-883
Purpose To determine whether sentinel lymph node (LN) sampling (SLNS) could reduce the number of nodes required to characterize micrometastatic disease (MMD) in patients with potentially curable colon cancer. Patients and Methods Cancer and Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0958e351a9b21fabed085290a8a22ff3
https://doi.org/10.1200/jco.2005.03.6038
https://doi.org/10.1200/jco.2005.03.6038
Autor:
James J. Vredenburgh, John H. Sampson, Sridharan Gururangan, Annick Desjardins, Roger E. McLendon, James M. Provenzale, David A. Reardon, Alan Swaisland, Allan H. Friedman, James E. Herndon, Jeremy N. Rich, Sith Sathornsumetee, Jeannette M. Dowell, Jennifer A. Quinn, Sandy Tourt-Uhlig, Robert Smith, Judith S. Ochs, Peggy Lyons, Darell D. Bigner, Henry S. Friedman
Publikováno v:
Clinical Cancer Research. 12:860-868
Purpose: To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of gefitinib, a receptor tyrosine kinase inhibitor of the epidermal growth factor receptor, plus sirolimus, an inhibitor of the mammalian target of rapamycin, amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a503381ae1bd14f74c63fc3ebddeaf
https://doi.org/10.1158/1078-0432.ccr-05-2215
https://doi.org/10.1158/1078-0432.ccr-05-2215
Autor:
David A, Reardon, Merrill J, Egorin, Jennifer A, Quinn, Jeremy N, Rich, Sridharan, Gururangan, Idharan, Gururangan, James J, Vredenburgh, Annick, Desjardins, Sith, Sathornsumetee, James M, Provenzale, James E, Herndon, Jeannette M, Dowell, Michael A, Badruddoja, Roger E, McLendon, Theodore F, Lagattuta, Kimberly P, Kicielinski, Gregor, Dresemann, John H, Sampson, Allan H, Friedman, August J, Salvado, Henry S, Friedman
Publikováno v:
Journal of Clinical Oncology. 23:9359-9368
Purpose We performed a phase II study to evaluate the combination of imatinib mesylate, an adenosine triphosphate mimetic, tyrosine kinase inhibitor, plus hydroxyurea, a ribonucleotide reductase inhibitor, in patients with recurrent glioblastoma mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26786e36dbac3be97635dd2369b6ca1d
https://doi.org/10.1200/jco.2005.03.2185
https://doi.org/10.1200/jco.2005.03.2185
Autor:
James W. Fleshman, Brent W. Miedema, Jeannette M. Dowell, Robert J. Mayer, Mark Redston, Monica M. Bertagnolli, Carolyn C. Compton, Michael J. Zinner, Jiri Bem, Donna Niedzwiecki
Publikováno v:
Annals of Surgery. 240:624-630
Objective and Summary Background Data: Sentinel lymph node (LN) sampling, a technique widely used to manage breast cancer and melanoma, seeks to select LNs that accurately predict regional node status and can be extensively examined to identify nodal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c739488f70eb6fe8560eaeec425cde
https://doi.org/10.1097/01.sla.0000140753.41357.20
https://doi.org/10.1097/01.sla.0000140753.41357.20
Autor:
Linda Wasserman, Christian N. Arnold, C. Richard Boland, Jeannette M. Dowell, Monica M. Bertagnolli, Ajay Goel, Donna Niedzwiecki, Carolyn C. Compton, Robert J. Mayer
Publikováno v:
Cancer Biology & Therapy. 3:960-964
Introduction: Germ-line mutations of the APC gene are associated with familial adenomatous polyposis, and somatic mutations occur frequently in sporadic colorectal cancer. However, to abrogate APC function, both alleles must be inactivated. Recently,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0552da4bf0c6c248627448d8c633546
https://doi.org/10.4161/cbt.3.10.1113
https://doi.org/10.4161/cbt.3.10.1113
Autor:
Deborah H. Allen, Amy Walker, Jeremy N. Rich, Sandra Tourt-Uhlig, Cindy Bohlin, Allan H. Friedman, John H. Sampson, Susanne Jackson, Mary Lou Affronti, Sridharan Gururangan, Karen Ziegler, James M. Provenzale, Jennifer A. Quinn, Michael A. Badruddoja, James E. Herndon, James J. Vredenburgh, Darrell D. Bigner, David A. Reardon, Steven Silverman, Henry S. Friedman, Jeannette M. Dowell
Publikováno v:
Neuro-Oncology. 6:134-144
In preclinical studies, BCNU, or 1,3-bis(2-chloroethyl)-1-nitrosourea, plus CPT-11 (irinotecan) exhibits schedule-dependent, synergistic activity against malignant glioma (MG). We previously established the maximum tolerated dose of CPT-11 when admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::660f8c22a6888ddf0a50b9b1a35e3885
https://doi.org/10.1215/s1152851703000413
https://doi.org/10.1215/s1152851703000413
Autor:
Brian K. Auge, David F. Paulson, Ari D. Silverstein, Alon Z. Weizer, Philipp Dahm, Jeannette M. Dowell
Publikováno v:
Urology. 63:746-750
To perform a detailed comparison of the in-house hospital costs of patients undergoing radical perineal prostatectomy (RPP) and radical retropubic prostatectomy (RRP) performed with or without bilateral staging lymph node dissection (BPLND) for local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931d26af499ac2d65bf012ccad7a62dc
https://doi.org/10.1016/j.urology.2003.11.007
https://doi.org/10.1016/j.urology.2003.11.007
Autor:
Carol J. Wikstrand, Henry S. Friedman, Terry S. Peery, Jennifer A. Quinn, Sandra Tourt-Uhlig, Janet Dancey, Lauren B. Van Duyn, Roger E. McLendon, James C. Kao, Allan H. Friedman, James J. Vredenburgh, Kara Penne, Darell D. Bigner, James E. Herndon, Timothy T. Stenzel, Jeremy N. Rich, David A. Reardon, John H. Sampson, Jeannette M. Dowell, B.K. Ahmed Rasheed
Publikováno v:
Journal of Clinical Oncology. 22:133-142
Purpose To evaluate the efficacy and tolerability of gefitinib (ZD1839, Iressa; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. Patients and Methods This was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad9c7c858a54335e8e1e9c338aafe0d
https://doi.org/10.1200/jco.2004.08.110
https://doi.org/10.1200/jco.2004.08.110